Related Experiment Videos
Rational design of allosteric ribozymes
1Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut, 06520-8103, USA.
Chemistry & Biology
|June 1, 1997
Summary
Researchers engineered the first allosteric ribozymes, demonstrating RNA can be regulated like protein enzymes. These novel RNA constructs offer precise control over catalytic rates using small effector molecules.
Area of Science:
- Biochemistry
- Molecular Biology
- Synthetic Biology
Background:
- Cellular processes rely on metabolic pathway control, often achieved through allosteric regulation of protein enzymes.
- While RNA molecules (ribozymes) catalyze reactions, true allosteric regulation analogous to protein enzymes has not been observed.
- Recent advances show RNA can form specific small-molecule receptors (aptamers).
Purpose of the Study:
- To investigate if ribozyme catalytic activity can be controlled by effector molecules.
- To design and create conjoined aptamer-ribozyme complexes for allosteric regulation.
- To establish the first example of an allosteric ribozyme.
Main Methods:
- Conjoining an ATP-binding RNA aptamer to a self-cleaving ribozyme.
- Assessing the catalytic rate of the construct in the presence of various nucleotides.
- Introducing mutations in the aptamer domain to evaluate the specificity and mechanism of allosteric control.
Main Results:
- The first allosteric ribozyme was created, showing ATP-specific control over catalytic rate.
- A 180-fold reduction in catalytic rate was observed with adenosine or ATP, but not other nucleotides.
- Mutations disrupting ATP binding or altering aptamer-ribozyme proximity abolished allosteric control.
- Allosteric hammerhead ribozymes activated by ATP and a theophylline-controlled ribozyme were also developed.
Conclusions:
- Catalytic RNAs can be regulated via allosteric mechanisms, similar to protein enzymes.
- Rational design strategies enable the engineering of novel catalytic polynucleotides with effector-controlled rates.
- This work opens possibilities for creating precisely regulated RNA-based molecular systems.